Boston Scientific had better results in Q1 than predicted
Medtech firm Boston Scientific raises lower estimates in its guidance following a better start to the year than predicted.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Medtech firm and endoscope manufacturer Boston Scientific had much better results for Q1 than predicted.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast CEO on buying spree: "Something has to happen"
For subscribers
Coloplast CEO urged to take action: Release the billions!
For subscribers
Ambu ready for price war on market for single-use devices
For subscribers
